Biolase and Stratasys Reach 3D Printing Distribution Deal

February 20, 2014 by Alan Gardner Business

Share this Article

There is no questions about it, the 3D printing market is growing, spreading its reach to encompass a variety of industries all over the planet. Today, Stratasys and Biolase (NASDAQ: BIOL) have entered a reseller agreement, whereby Biolase will begin reselling Stratasys’ Objet30 Orthodesk printers among some of their other machines.

Biolase is the world’s largest manufacturer and distributor of dental lasers. This agreement will allow them to market and sell Stratasys 3d printers for the use within the dental industry. The key printer in this deal will be the Objet30 Orthodesk which allows dentists to fabricate delivery and positioning trays, stone models, surgical guides, orthodontic appliances, models for clear aligners, and retainers.

Federico Pignatelli, Chairman and CEO of Biolase, said today, “We are thrilled to be chosen as the first distributor of Stratasys’ dental 3-D printing products for the in-office, chair-side market. We believe that 3-D printing will be a revolutionary factor in dental restoration in the new digital era of dentistry. By combining high-end digital imaging, first in class laser tissue management, intra-oral scanning, CAD/CAM design, chair-side milling, and 3-D printing, dental offices can accurately and rapidly produce a wide range of restorations and appliances. We believe that Stratasys will be the perfect long-term partner for BIOLASE as more and more dental offices recognize the excellent return on investment a digital office provides, as well as the increased convenience and benefits high-tech products provide their patients.”

The Vice President of Vertical Sales-Americas of Stratasys, Craig Perry, explained why this agreement will benefit both companies,

“Our Objet30 Series is the world’s most versatile desktop 3-D printer. It is compact, affordable, and easy to use. With patented, industry-leading Polyjet 3-D printing technology, it offers all of the advantages of a 3-D printer, in a package just right for a dental office.”

This appears to be a very beneficial agreement for both companies, and shareholders seem to feel this way as well. Both stocks are up on the day, with Biolase trading up 12%, and Stratasys up 1.75% since the open. Nearly all the major 3D printing stocks in the U.S. are up today as well.

Discuss this recent distribution deal.